1. Disclaimer: All information contained in this report has been obtained from sources believed to be accurate by Gyan Research and
Analytics Pvt. Ltd. (Gyan). While reasonable care has been taken in its preparation, Gyan makes no representation or warranty,
express or implied, as to the accuracy, timeliness or completeness of any such information. The information contained herein may
be changed without notice. All information should be considered solely as statements of opinion and Gyan will not be liable for
any loss incurred by users from any use of the publication or contents.
Indian Diagnostic Industry: The Pill for Success

2. Indian Diagnostic Industry: The Pill for Success
2 | P a g e
© Gyan Research and Analytics Pvt. Ltd., 2014
Synopsis
Modern life is beset with health issues, which have increased manifold due to contemporary lifestyles.
Therefore, healthcare has become a crucial aspect of our lives.
The healthcare industry has been forced to come up with new procedures and cures, and effective
diagnosis has become the first step towards treatment.
The global healthcare industry generated revenues of USD 6 trillion in 2011. The diagnostic segment has
grown in leaps and bounds. This crucial segment is subdivided into two broad categories - in-vitro
diagnostics and imaging diagnostics. The global in-vitro market generated revenues of USD 52.04 billion
in 2012. This is estimated to reach USD 87 billion by 2018. The global imaging market generated revenues
of USD 25.43 billion in 2012, which is to touch USD 39 billion by 2018.
Several well-known players such as Apollo Hospitals, Metropolis Healthcare and Fortis Healthcare are
entering the market with new diagnostic centers, equipped with the latest technologies. Some players
have ventured into Tier-III and Tier-IV cities as well, as there’s a huge untapped potential in these remote
areas. These diagnostic centers are currently upgrading the existing equipment from traditional to
high-end automated systems. Consequently, purchase of second-hand sophisticated machinery has gone
up.
The in-vitro segment of the industry accrued revenues of USD 463.50 million in 2012, which is estimated
to touch USD 1,254 million by 2018. The imaging-diagnosis segment generated revenues of USD 645.10
million in 2012, projected to reach USD 1,000 million by 2018. These figures clearly indicate that the
diagnostic industry in India is set to flourish in the coming five years.
Increasing health awareness programmes and wellness campaigns, growing popularity of clinical
diagnosis, entry of various new drugs into the market and a sharp rise in competition among the various
diagnostic chains are some of the factors that will shape the growth of the industry.

3. Indian Diagnostic Industry: The Pill for Success
3 | P a g e
© Gyan Research and Analytics Pvt. Ltd., 2014
Table of Contents
1. Overview
2. Global Perspective
3. Indian Diagnostic Industry
3.1 In-vitro Diagnostic Industry
3.1.1 Market Share
3.1.2 Market Segmentation
3.2 Imaging Diagnostic Industry
3.2.1 Market Share
3.2.2 Market Segmentation
4. Diagnostic and Pathology Labs Test Services
5. Cost Structure of Various Diagnoses in India
6. Opportunities
7. Collaborations
8. Government Policies and Regulations
9. Outlook

4. Indian Diagnostic Industry: The Pill for Success
4 | P a g e
© Gyan Research and Analytics Pvt. Ltd., 2014
GYAN RESEARCH AND ANALYTICS PVT. LTD.
Corporate Office:
LG 37-38, Ansal Fortune
Arcade, Sector-18,
Noida- 201 301
Delhi NCR, INDIA
Phone: +91-120-4235181
Regd. Office:
298-A, Pocket 2
Mayur Vihar Phase -1
Delhi 110 091, INDIA
Central Delivery Centre:
BD-9, Sector-1,
Salt Lake City
Kolkata- 700 064, INDIA
Phone: +91-33-40060084
E-mail: reports@gyananalytics.com
Website: www.gyananlytics.com